Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Movel Medical Aesthetics is a specialized healthcare company dedicated to the development and distribution of advanced aesthetic solutions. The company's core portfolio features high-purity botulinum toxin type A and a range of hyaluronic acid-based dermal fillers. These products are designed to address common cosmetic concerns such as dynamic wrinkles, volume loss, and skin hydration. Movel Medical Aesthetics operates with a focus on the global market, ensuring that its manufacturing processes meet international safety standards. By providing cost-effective yet high-quality medical aesthetic products, the company supports practitioners in delivering effective non-surgical rejuvenation treatments. Their flagship brand, Moveltox, has gained recognition for its efficacy and safety profile in various clinical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Movel Medical Aesthetics.